HR 1051 · 119th Congress
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.
This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Latest action
2025-02-06 — Referred to the House Committee on Energy and Commerce.
Sponsor
Nikki BudzinskiCosponsors
Cosponsors not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-1051
to populate.
Action history
Action history not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-1051
to populate.
Subjects
Subjects not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-1051
to populate.
Titles
Titles not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-1051
to populate.
Summaries
Summaries not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-1051
to populate.
Vote history
No votes recorded for this bill yet.
Coming in later phases
Committee path (Phase 4)
Committee referrals and reports will appear here.
Search within this bill (Phase 5)
Bill text will become searchable here.